课题基金 / 基金详情

Treating Age-Related Macular Degeneration by Mitigating Inflammation, Oxidative Stress, and Lipid Accumulation through CD36 Modulation

Treating Age-Related Macular Degeneration by Mitigating Inflammation, Oxidative Stress, and Lipid Accumulation through CD36 Modulation
通过 CD36 调节减轻炎症、氧化应激和脂质积累来治疗年龄相关性黄斑变性
批准号:
468104
负责人:
Lubell William D
金额:
$60.75万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-09-01 至 2025-09-01

项目摘要

项目成果

Lubell William D的其他基金

相似基金

相关文献

中文摘要
翻译
视网膜相关性黄斑变性(AMD)是成人视力丧失的主要原因。AMD以干性和湿性临床形式存在。干型的早期特征是视网膜下层(视网膜壁的中间层)的膜增厚
英文摘要
Age-related Macular degeneration (AMD) is the leading cause of adult vision loss. AMD presents itself in dry and wet clinical forms. The early phase of the dry form is characterized by thickening of membranes in the sub-retina, a middle layer of the wall
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin-1 Receptor Modulating Therapy for Treating Macular Degeneration
  • 批准号:
    478746
  • 项目类别:
    Operating Grants
  • 资助金额:
    $37.62万
  • 财政年份:
    2023
  • 负责人:
    Lubell William D
  • 依托单位:
Safe and selective anti-parasite therapy targeting ribosome and glycosome function
  • 批准号:
    451337
  • 项目类别:
    Operating Grants
  • 资助金额:
    $64.65万
  • 财政年份:
    2021
  • 负责人:
    Lubell William D
  • 依托单位:
Allosteric Modulation of the Urotensin Receptor with Small-Molecule Peptide Mimics
  • 批准号:
    407925
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.73万
  • 财政年份:
    2019
  • 负责人:
    Lubell William D
  • 依托单位:
Azacyclopeptide Modulators of Immuno-metabolism to Treat Age-Related Macular Degeneration
  • 批准号:
    396402
  • 项目类别:
    Operating Grants
  • 资助金额:
    $29.4万
  • 财政年份:
    2018
  • 负责人:
    Lubell William D
  • 依托单位:
海外基金